- AU$213.55m
- AU$208.63m
- AU$60.12m
- 100
- 38
- 91
- 87
Annual balance sheet for XRF Scientific, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 3.63 | 5.26 | 6.65 | 10.4 | 12 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3.77 | 4.48 | 6.23 | 8.63 | 9.52 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 19.1 | 22.7 | 28.9 | 36.5 | 39.2 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 9.28 | 8.75 | 8.66 | 10.4 | 10.8 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 45.2 | 48.4 | 55.6 | 65.5 | 68.2 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 7.8 | 8.44 | 9.66 | 11.6 | 10.4 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 9.53 | 9.27 | 12.1 | 16.3 | 13.3 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 35.6 | 39.1 | 43.5 | 49.3 | 54.9 |
| Total Liabilities & Shareholders' Equity | 45.2 | 48.4 | 55.6 | 65.5 | 68.2 |
| Total Common Shares Outstanding |